Antibioticresistancedecisionsinminutes,notdays.
BactoAI uses machine learning to predict antimicrobial resistance from bacterial genomes — before lab results come back.
A silent pandemic is outpacing the drugs we have to fight it.
"Antimicrobial resistance is one of the top ten global public health threats facing humanity."
Antimicrobial resistance is one of the greatest global health threats.
Traditional culture-based diagnostics delay clinical decisions, contributing to inappropriate antibiotic use, prolonged hospital stays, and increasing antimicrobial resistance.
Deaths directly attributable to AMR each year worldwide.
Traditional antimicrobial susceptibility testing turnaround.
Patients receive empirical antibiotics before lab confirmation.
Meet BactoAI
BactoAI analyzes bacterial genomic data using machine learning to predict antibiotic resistance before conventional laboratory testing is completed.
Clinical presentation & bacterial infection identified.
Bacterial isolate collected from the patient.
Whole genome sequence generated (FASTA / FASTQ).
ML models analyze genomic features.
Resistance profile & confidence per antibiotic.
Clinician makes an informed prescribing decision.
Try it yourself. Watch a genome become a treatment recommendation.
Pick a sample isolate, then click Analyze sample to simulate the BactoAI workflow — upload, pre-processing, model inference, and clinician-ready report.
- Drag-and-drop FASTA / FASTQ upload
- Per-antibiotic resistance & confidence
- PDF clinical reports
- Audit-ready result history
Select a sample to analyze
Four de-identified bacterial whole-genome samples from our validation set.
Run the prediction
Request a demo on your own isolates
Send us a request and our team will run BactoAI against your genomes with you.
Evidence-based development.
Our machine learning models are developed on curated bacterial genomes and rigorously evaluated. Prospective clinical validation is ongoing with partner laboratories.
- Trained on curated public bacterial genome datasets
- Internal cross-validated performance metrics
- Clinical validation studies in progress
Reported figures reflect internal model development. Performance on prospective clinical isolates will be reported upon completion of ongoing validation.
Bring genome-driven decisions into your hospital or lab.
See a live demo of BactoAI on your own isolates, or talk to us about launching a pilot in your region.